8-K ·Filed May 7, 2026

TFX

TELEFLEX INC
MIXED
Impact 6/10
Horizondays Processed4mo ago SEC0000096943-26-000048
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The EPS beat may drive a short-term positive move, but unchanged guidance and declining margins suggest caution. Monitor Q2 results for margin stabilization and progress on divestitures. The $1B buyback authorization partially offsets operational headwinds.

DirectionMixed
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
TFX ▲ +3.89% at T+60d
NEUTRAL call ✓ call won +3.89% · α vs SPY +1.78% · entry $131.59 → $136.71
Entry anchored
May 7, 2026
via day open
T+1d
+0.72%
call +0.72% · α -0.11%
$132.54
settled 5mo ago
T+5d
-1.18%
call -1.18% · α -2.69%
$130.04
settled 5mo ago
T+20d
-2.31%
call -2.31% · α -5.44%
$128.56
settled 4mo ago
T+60d
+3.89%
call +3.89% · α +1.78%
$136.71
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Teleflex Q1 2026 adjusted EPS of $1.39 beat consensus by 14%, and pro forma adjusted constant currency revenue grew 5.1% year-over-year, in line with full-year guidance. However, GAAP EPS was a loss of ($0.11) due to restructuring costs, adjusted operating margin compressed 510 bps to 18.1%, and adjusted EPS declined 3.5% YoY. Full-year guidance was maintained, not raised, tempering the beat's impact.

Key Financial Metrics

EPS
$1.39
est $1.22 · +13.9%
Revenue
$548.3M
est $537.6M · +2.0%
Rating
beat
Guidance
GAAP $2,280M-$2,300M; pro forma adj constant currency 4.5%-5.5%
maintained
Free Cash Flow
$27.9M
Gross Margin
61.4%

Key Facts

  • Adjusted diluted EPS from continuing ops $1.39 vs consensus $1.22 (14% beat)
  • Revenue $548.3M vs consensus $537.6M (2% beat, in line per threshold)
  • Pro forma adjusted constant currency revenue growth 5.1% (within 4.5%-5.5% guidance)
  • GAAP EPS $(0.11) from continuing ops due to $79.2M in pre-tax adjustments
  • Adjusted operating margin 18.1%, down from 23.2% in Q1 2025
  • Full-year 2026 guidance maintained: adjusted EPS $6.25-$6.55, pro forma revenue growth 4.5%-5.5%
  • Company expects strategic divestitures to close in H2 2026; $1B share repurchase to begin in Q2

Financial Impact

Q1 adjusted EPS beat by $0.17 (14%), but annual guidance unchanged; stranded costs of $90M weigh on margins

revenueepsoperating margincash flow

Risk Factors

  • Divestiture delays or worse-than-expected proceeds
  • Stranded costs exceeding $90M annual estimate
  • Further margin compression from tariffs and supplier disruptions
  • Integration costs from Vascular Intervention acquisition

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
29% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000096943-26-000048
Exhibit: exhibit992to5-7x2026req1.htm0000096943-26-000048
Document: tfx-20260507.htm0000096943-26-000048
Document: 0000096943-26-000048-index-headers.html0000096943-26-000048
Document: 0000096943-26-000048-index.html0000096943-26-000048
Document: 0000096943-26-000048.txt0000096943-26-000048
8-K Data (Synthetic)0000096943-26-000048
9 reports for TFX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TFX — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
MIXED ★ 6/10
$138.89 $139.96▲ +0.77%▲ +0.17%$124.12 (−10.63%)
Jul 2, 2026
13w ago
Court Ruling
BULLISH ★ 6/10
$133.99 $132.30▼ −1.26%▼ −0.85%$124.12 (−7.37%)
Jun 22, 2026
14w ago
Institutional Cluster
MIXED ★ 4/10
$121.67 $134.61▲ +10.64%▲ +10.78%$124.12 (+2.01%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$127.87 $130.16▲ +1.79%▲ +1.59%$124.12 (−2.93%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$132.15 $134.04▲ +1.43%▼ −2.19%$124.12 (−6.08%)
Jun 1, 2026
17w ago
8-K
NEUTRAL ★ 4/10
$127.31 $127.49▲ +0.14%▲ +2.45%$124.12 (−2.51%)
May 27, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$128.90 $127.79▼ −0.86%▲ +1.83%$124.12 (−3.71%)
May 7, 2026
21w ago
8-K
MIXED ★ 6/10
$131.59 $128.56▼ −2.31%▼ −5.44%$124.12 (−5.68%)
Feb 26, 2026
31w ago
8-K
MIXED ★ 7/10
$118.39 $110.38▼ −6.77%▼ −0.36%$124.12 (+4.84%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access